TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them.
World TB Day 2018
TB Alliance is supporting over 30 activities, including TB screenings, educational events and political advocacy in support of TB research.
Nancy Miller-Rich Joins TB Alliance Board
Miller-Rich has 35 years of experience in the pharmaceutical industry, including global business development at Merck Pharmaceuticals
ZeNix Clinical Trial Announced
New trial evaluates whether the efficacy of the BPaL drug regimen can be maintained with reduced toxicity
Tomorrow's Cures
Accelerating the Pace
TB Alliance is not just developing new drugs, but changing the way TB drugs are developed.
Engaging Communities
Affordable, Accessible
TB Alliance's mission is not complete until new drugs are in the hands of those who need them.
The TB Facts
-
1.7 Million
Tuberculosis (TB) is a global pandemic, killing someone approximately every 18 seconds — about 1.7 million in 2016 alone.
The TB Pandemic » -
6-30 Months
Today's TB drug regimen takes too long to cure, is too complicated to administer, and can be toxic.
Inadequate Treatment » -
30+ Projects
Promise in the pipeline means new hope in stopping TB.
Developing Regimens »
Our Pipeline
TB Alliance manages the largest pipeline of new TB drugs in history.
